Starpharma Holdings Ltd (SPL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has a cash flow conversion efficiency ratio of 0.182x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$3.91 Million ≈ $2.77 Million USD) by net assets (AU$21.48 Million ≈ $15.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Starpharma Holdings Ltd (SPL) net asset quality to measure how much of total assets are equity-financed.
Starpharma Holdings Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Starpharma Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SPL operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Starpharma Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Starpharma Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Metro Mining Limited
F:6ME
|
-0.025x |
|
Claros Mortgage Trust Inc
NYSE:CMTG
|
0.005x |
|
First Savings Financial Group Inc
NASDAQ:FSFG
|
0.544x |
|
Sindoh
KO:029530
|
0.023x |
|
Ritek Corp
TW:2349
|
-0.009x |
|
Backblaze Inc
NASDAQ:BLZE
|
0.069x |
|
Senao Networks
TWO:3558
|
0.049x |
|
Magnora ASA
OL:MGN
|
-0.119x |
Annual Cash Flow Conversion Efficiency for Starpharma Holdings Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Starpharma Holdings Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Starpharma Holdings Ltd (SPL) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$19.00 Million ≈ $13.44 Million |
AU$-6.76 Million ≈ $-4.78 Million |
-0.356x | -43.37% |
| 2024-06-30 | AU$28.12 Million ≈ $19.89 Million |
AU$-6.98 Million ≈ $-4.94 Million |
-0.248x | +36.16% |
| 2023-06-30 | AU$34.81 Million ≈ $24.63 Million |
AU$-13.53 Million ≈ $-9.58 Million |
-0.389x | -42.92% |
| 2022-06-30 | AU$48.39 Million ≈ $34.24 Million |
AU$-13.16 Million ≈ $-9.31 Million |
-0.272x | -14.43% |
| 2021-06-30 | AU$62.30 Million ≈ $44.08 Million |
AU$-14.81 Million ≈ $-10.48 Million |
-0.238x | +30.90% |
| 2020-06-30 | AU$31.33 Million ≈ $22.17 Million |
AU$-10.78 Million ≈ $-7.62 Million |
-0.344x | -40.99% |
| 2019-06-30 | AU$42.40 Million ≈ $30.00 Million |
AU$-10.34 Million ≈ $-7.32 Million |
-0.244x | -27.43% |
| 2018-06-30 | AU$53.28 Million ≈ $37.70 Million |
AU$-10.20 Million ≈ $-7.22 Million |
-0.191x | +31.13% |
| 2017-06-30 | AU$60.98 Million ≈ $43.15 Million |
AU$-16.95 Million ≈ $-12.00 Million |
-0.278x | +22.85% |
| 2016-06-30 | AU$49.42 Million ≈ $34.97 Million |
AU$-17.81 Million ≈ $-12.60 Million |
-0.360x | +0.59% |
| 2015-06-30 | AU$37.56 Million ≈ $26.57 Million |
AU$-13.62 Million ≈ $-9.63 Million |
-0.363x | -21.73% |
| 2014-06-30 | AU$32.95 Million ≈ $23.31 Million |
AU$-9.81 Million ≈ $-6.94 Million |
-0.298x | -39.76% |
| 2013-06-30 | AU$45.97 Million ≈ $32.53 Million |
AU$-9.79 Million ≈ $-6.93 Million |
-0.213x | -6.11% |
| 2012-06-30 | AU$48.65 Million ≈ $34.42 Million |
AU$-9.77 Million ≈ $-6.91 Million |
-0.201x | +14.13% |
| 2011-06-30 | AU$27.69 Million ≈ $19.59 Million |
AU$-6.48 Million ≈ $-4.58 Million |
-0.234x | -124.47% |
| 2010-06-30 | AU$34.84 Million ≈ $24.65 Million |
AU$-3.63 Million ≈ $-2.57 Million |
-0.104x | +34.07% |
| 2009-06-30 | AU$25.50 Million ≈ $18.04 Million |
AU$-4.03 Million ≈ $-2.85 Million |
-0.158x | +39.82% |
| 2008-06-30 | AU$20.38 Million ≈ $14.42 Million |
AU$-5.35 Million ≈ $-3.79 Million |
-0.263x | -99.82% |
| 2007-06-30 | AU$25.72 Million ≈ $18.20 Million |
AU$-3.38 Million ≈ $-2.39 Million |
-0.131x | +62.60% |
| 2006-06-30 | AU$21.32 Million ≈ $15.08 Million |
AU$-7.49 Million ≈ $-5.30 Million |
-0.351x | +39.71% |
| 2005-06-30 | AU$9.97 Million ≈ $7.05 Million |
AU$-5.81 Million ≈ $-4.11 Million |
-0.583x | -76.57% |
| 2004-06-30 | AU$17.59 Million ≈ $12.45 Million |
AU$-5.81 Million ≈ $-4.11 Million |
-0.330x | +22.04% |
| 2002-06-30 | AU$17.27 Million ≈ $12.22 Million |
AU$-7.31 Million ≈ $-5.17 Million |
-0.423x | -329.93% |
| 2001-06-30 | AU$24.92 Million ≈ $17.63 Million |
AU$-2.45 Million ≈ $-1.74 Million |
-0.098x | -- |
About Starpharma Holdings Ltd
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurr… Read more